Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.

Belanoff JK, Blasey CM, Clark RD, Roe RL.

Eur J Pharmacol. 2011 Mar 25;655(1-3):117-20. doi: 10.1016/j.ejphar.2011.01.019. Epub 2011 Jan 24.

PMID:
21269600
[PubMed - indexed for MEDLINE]
2.

Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain.

Belanoff JK, Blasey CM, Clark RD, Roe RL.

Diabetes Obes Metab. 2010 Jun;12(6):545-7. doi: 10.1111/j.1463-1326.2009.01185.x.

PMID:
20518810
[PubMed - indexed for MEDLINE]
3.

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.

Beebe KL, Block T, Debattista C, Blasey C, Belanoff JK.

Behav Brain Res. 2006 Aug 10;171(2):225-9. Epub 2006 Jun 19.

PMID:
16782211
[PubMed - indexed for MEDLINE]
4.

Mifepristone treatment of olanzapine-induced weight gain in healthy men.

Gross C, Blasey CM, Roe RL, Allen K, Block TS, Belanoff JK.

Adv Ther. 2009 Oct;26(10):959-69. doi: 10.1007/s12325-009-0070-1. Epub 2009 Nov 4.

PMID:
19888560
[PubMed - indexed for MEDLINE]
5.

Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.

Deng C, Lian J, Pai N, Huang XF.

J Psychopharmacol. 2012 Sep;26(9):1271-9. doi: 10.1177/0269881112449396. Epub 2012 Jun 13.

PMID:
22695490
[PubMed - indexed for MEDLINE]
6.

Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.

Shobo M, Yamada H, Mihara T, Kondo Y, Irie M, Harada K, Ni K, Matsuoka N, Kayama Y.

Behav Brain Res. 2011 Jan 20;216(2):561-8. doi: 10.1016/j.bbr.2010.08.046. Epub 2010 Sep 15.

PMID:
20816897
[PubMed - indexed for MEDLINE]
7.

Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Davoodi N, Kalinichev M, Korneev SA, Clifton PG.

Psychopharmacology (Berl). 2009 May;203(4):693-702. doi: 10.1007/s00213-008-1415-1. Epub 2008 Dec 4.

PMID:
19052729
[PubMed - indexed for MEDLINE]
8.

Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.

Patil BM, Kulkarni NM, Unger BS.

Eur J Pharmacol. 2006 Dec 3;551(1-3):112-5. Epub 2006 Sep 16.

PMID:
17046744
[PubMed - indexed for MEDLINE]
9.

Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.

Fell MJ, Marshall KM, Williams J, Neill JC.

J Psychopharmacol. 2004 Jun;18(2):149-55.

PMID:
15260902
[PubMed - indexed for MEDLINE]
10.

Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.

Minet-Ringuet J, Even PC, Goubern M, Tomé D, de Beaurepaire R.

Appetite. 2006 May;46(3):254-62. Epub 2006 Mar 23.

PMID:
16551485
[PubMed - indexed for MEDLINE]
11.

Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.

Weston-Green K, Huang XF, Deng C.

PLoS One. 2012;7(3):e33548. doi: 10.1371/journal.pone.0033548. Epub 2012 Mar 16.

PMID:
22438946
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A model for antipsychotic-induced obesity in the male rat.

Minet-Ringuet J, Even PC, Lacroix M, Tomé D, de Beaurepaire R.

Psychopharmacology (Berl). 2006 Sep;187(4):447-54. Epub 2006 Jun 17.

PMID:
16783538
[PubMed - indexed for MEDLINE]
13.

Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.

Gross C, Blasey CM, Roe RL, Belanoff JK.

Obesity (Silver Spring). 2010 Dec;18(12):2295-300. doi: 10.1038/oby.2010.51. Epub 2010 Mar 25.

PMID:
20339369
[PubMed - indexed for MEDLINE]
14.

Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.

Han M, Deng C, Burne TH, Newell KA, Huang XF.

Psychoneuroendocrinology. 2008 Jun;33(5):569-80. doi: 10.1016/j.psyneuen.2008.01.018. Epub 2008 Mar 20.

PMID:
18358632
[PubMed - indexed for MEDLINE]
15.

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.

Cooper GD, Harrold JA, Halford JC, Goudie AJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):428-36. Epub 2007 Sep 22.

PMID:
17933447
[PubMed - indexed for MEDLINE]
16.

The role of thermogenesis in antipsychotic drug-induced weight gain.

Stefanidis A, Verty AN, Allen AM, Owens NC, Cowley MA, Oldfield BJ.

Obesity (Silver Spring). 2009 Jan;17(1):16-24. doi: 10.1038/oby.2008.468. Epub 2008 Oct 30.

PMID:
19107124
[PubMed - indexed for MEDLINE]
17.

The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.

Lykkegaard K, Larsen PJ, Vrang N, Bock C, Bock T, Knudsen LB.

Schizophr Res. 2008 Aug;103(1-3):94-103. doi: 10.1016/j.schres.2008.05.011. Epub 2008 Jun 25.

PMID:
18579346
[PubMed - indexed for MEDLINE]
18.

LLY-2707, a novel nonsteroidal glucocorticoid antagonist that reduces atypical antipsychotic-associated weight gain in rats.

Sindelar DK, Carson MW, Morin M, Shaw J, Barr RJ, Need A, Alexander-Chacko J, Coghlan M, Gehlert DR.

J Pharmacol Exp Ther. 2014 Jan;348(1):192-201. doi: 10.1124/jpet.113.205864. Epub 2013 Oct 25.

PMID:
24163440
[PubMed - indexed for MEDLINE]
19.

An animal model of antipsychotic-induced weight gain.

Arjona AA, Zhang SX, Adamson B, Wurtman RJ.

Behav Brain Res. 2004 Jun 4;152(1):121-7.

PMID:
15135975
[PubMed - indexed for MEDLINE]
20.

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human.

Pouzet B, Mow T, Kreilgaard M, Velschow S.

Pharmacol Biochem Behav. 2003 Apr;75(1):133-40.

PMID:
12759121
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk